PanGen Biotech Inc. (KOSDAQ: 222110)

PanGen Biotech Revenue

PanGen Biotech had revenue of 4.60B KRW in the quarter ending September 30, 2024, with 129.39% growth. This brings the company's revenue in the last twelve months to 13.72B, up 179.56% year-over-year. In the year 2023, PanGen Biotech had annual revenue of 7.32B with 12.53% growth.

• Revenue (ttm): 13.72B
• Revenue Growth: +179.56%
• P/S Ratio: 4.54
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 72.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.32B	814.47M	12.53%
Dec 31, 2022	6.50B	-1.43B	-18.08%
Dec 31, 2021	7.94B	1.74B	28.18%
Dec 31, 2020	6.19B	3.31B	114.87%
Dec 31, 2019	2.88B	-2.80B	-49.27%